220 related articles for article (PubMed ID: 11880531)
1. Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.
Pommier B; Beslot F; Simon A; Pophillat M; Matsui T; Dauge V; Roques BP; Noble F
J Neurosci; 2002 Mar; 22(5):2005-11. PubMed ID: 11880531
[TBL] [Abstract][Full Text] [Related]
2. Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice.
Rünkorg K; Veraksits A; Kurrikoff K; Luuk H; Raud S; Abramov U; Matsui T; Bourin M; Kõks S; Vasar E
Behav Brain Res; 2003 Sep; 144(1-2):125-35. PubMed ID: 12946603
[TBL] [Abstract][Full Text] [Related]
3. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
4. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence.
Wen D; Ma CL; Zhang YJ; Meng YX; Ni ZY; Li SJ; Cong B
BMC Neurosci; 2012 Jun; 13():63. PubMed ID: 22682150
[TBL] [Abstract][Full Text] [Related]
6. The role of CCK2 receptors in the homeostasis of the opioid system.
Noble F; Roques BP
Drugs Today (Barc); 2003 Nov; 39(11):897-908. PubMed ID: 14702135
[TBL] [Abstract][Full Text] [Related]
7. Nociception increases during opioid infusion in opioid receptor triple knock-out mice.
Juni A; Klein G; Pintar JE; Kest B
Neuroscience; 2007 Jun; 147(2):439-44. PubMed ID: 17544222
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice.
Kurrikoff K; Kõks S; Matsui T; Bourin M; Arend A; Aunapuu M; Vasar E
Eur J Neurosci; 2004 Sep; 20(6):1577-86. PubMed ID: 15355324
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats.
Wen D; Sun D; Zang G; Hao L; Liu X; Yu F; Ma C; Cong B
Neuroscience; 2014 Sep; 277():14-25. PubMed ID: 24993476
[TBL] [Abstract][Full Text] [Related]
11. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
12. Role of the guanine nucleotide binding protein, Gα
Lamberts JT; Rosenthal LD; Jutkiewicz EM; Traynor JR
Psychopharmacology (Berl); 2018 Jan; 235(1):71-82. PubMed ID: 28971229
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of an opioid-mediated antinociceptive mechanism in transgenic mice over-expressing substance P in the spinal cord.
McLeod AL; Ritchie J; Cuello AC; Julien JP; Henry JL; Ribeiro-da-Silva A
Neuroscience; 2000; 96(4):785-9. PubMed ID: 10727796
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance.
Xie JY; Herman DS; Stiller CO; Gardell LR; Ossipov MH; Lai J; Porreca F; Vanderah TW
J Neurosci; 2005 Jan; 25(2):409-16. PubMed ID: 15647484
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
Fuchs PN; Roza C; Sora I; Uhl G; Raja SN
Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835
[TBL] [Abstract][Full Text] [Related]
16. Potentiated opioid analgesia in norepinephrine transporter knock-out mice.
Bohn LM; Xu F; Gainetdinov RR; Caron MG
J Neurosci; 2000 Dec; 20(24):9040-5. PubMed ID: 11124980
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
[TBL] [Abstract][Full Text] [Related]
18. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
19. Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits.
Vekovischeva OY; Zamanillo D; Echenko O; Seppälä T; Uusi-Oukari M; Honkanen A; Seeburg PH; Sprengel R; Korpi ER
J Neurosci; 2001 Jun; 21(12):4451-9. PubMed ID: 11404432
[TBL] [Abstract][Full Text] [Related]
20. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
Feng J; Kendig JJ
Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
